A clinical trial to investigate PTX-25

Trial Profile

A clinical trial to investigate PTX-25

Planning
Phase of Trial: Phase I

Latest Information Update: 01 May 2017

At a glance

  • Drugs PTX 25 (Primary)
  • Indications Cancer
  • Focus Adverse reactions; First in man
  • Most Recent Events

    • 25 May 2016 New trial record
    • 19 May 2016 An investigational new drug (IND) application filing is expected in 2017, according to a Pelican Therapeutics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top